Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Express Scripts
Argus Health
Boehringer Ingelheim

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,721,244

« Back to Dashboard

Summary for Patent: 5,721,244

Title: Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs
Abstract:The invention relates to combinations of angiotensin-converting enzyme inhibitors with calcium antagonists, processes for their preparation and their use as medicaments.
Inventor(s): Becker; Reinhard (Wiesbaden, DE), Henning; Rainer (Hattersheim am Main, DE), Ruger; Wolfgang (Kelkheim, DE), Teetz; Volker (Hofheim am Taunus, DE), Urbach; Hans Jorg (Kronberg/Taunus, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt an Main, DE)
Application Number:08/483,961
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,721,244

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany36 33 496.0Oct 02, 1986

International Patent Family for Patent: 5,721,244

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel84054► Subscribe
Germany3633496► Subscribe
Germany3780753► Subscribe
Germany19975008► Subscribe
Denmark516487► Subscribe
Denmark167904► Subscribe
Egypt18081► Subscribe
European Patent Office0265685► SubscribeSPC/GB98/047United Kingdom► Subscribe
European Patent Office0265685► Subscribe99C0001Belgium► Subscribe
European Patent Office0265685► SubscribeC980030Netherlands► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
Federal Trade Commission
Johnson and Johnson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus